Oncolytics Biotech Inc. (ONC.TO)
Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
At close: 03:59PM EDT
Currency in CAD
Valuation measures4
| Market cap (intra-day) | 110.11M |
| Enterprise value | 81.64M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 4.79 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 1.45 |
| 52-week change 3 | -32.09% |
| S&P500 52-week change 3 | 23.49% |
| 52-week high 3 | 4.4900 |
| 52-week low 3 | 1.2000 |
| 50-day moving average 3 | 1.5070 |
| 200-day moving average 3 | 1.9413 |
Share statistics
| Avg vol (3-month) 3 | 63.11k |
| Avg vol (10-day) 3 | 30.81k |
| Shares outstanding 5 | 75.42M |
| Implied shares outstanding 6 | 75.42M |
| Float 8 | 72.21M |
| % held by insiders 1 | 3.90% |
| % held by institutions 1 | 1.92% |
| Shares short (15 May 2024) 4 | 304.12k |
| Short ratio (15 May 2024) 4 | 6.7 |
| Short % of float (15 May 2024) 4 | 0.43% |
| Short % of shares outstanding (15 May 2024) 4 | 0.40% |
| Shares short (prior month 15 Apr 2024) 4 | 305.71k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 25 May 2018 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 105:1000 |
| Last split date 3 | 25 May 2018 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -63.83% |
| Return on equity (ttm) | -115.80% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -35.7M |
| Net income avi to common (ttm) | -28.21M |
| Diluted EPS (ttm) | -0.4000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 29.6M |
| Total cash per share (mrq) | 0.39 |
| Total debt (mrq) | 1.13M |
| Total debt/equity (mrq) | 4.91% |
| Current ratio (mrq) | 8.14 |
| Book value per share (mrq) | 0.31 |
Cash flow statement
| Operating cash flow (ttm) | -28.09M |
| Levered free cash flow (ttm) | -17.2M |
© 2024 Yahoo. All rights reserved.